Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells

被引:45
作者
Munoz-Alonso, Maria J. [1 ,2 ]
Gonzalez-Santiago, Laura [1 ,2 ]
Zarich, Natasha [3 ]
Martinez, Teresa [1 ]
Alvarez, Enrique [2 ]
Maria Rojas, Jose [3 ]
Munoz, Alberto [1 ]
机构
[1] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, E-28029 Madrid, Spain
[2] Colmenar Viejo, Pharma Mar SA, Madrid, Spain
[3] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
关键词
D O I
10.1124/jpet.107.132662
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Melanoma is the most aggressive skin cancer and a serious health problem worldwide because of its increasing incidence and the lack of satisfactory chemotherapy for late stages of the disease. The marine depsipeptide Aplidin (plitidepsin) is an antitumoral agent under phase II clinical development against several neoplasias, including melanoma. We report that plitidepsin has a dual effect on the human SK-MEL-28 and UACC-257 melanoma cell lines; at low concentrations ( <= 45 nM), it inhibits the cell cycle by inducing G 1 and G(2)/M arrest, whereas at higher concentrations it induces apoptosis as assessed by poly( ADP-ribose) polymerase cleavage and the appearance of a hypodiploid peak in flow cytometry analyses. Plitidepsin activates Rac1 GTPase and c-Jun NH2-terminal kinase (JNK). In addition, it induces AKT and p38 mitogen-activated protein kinase ( MAPK) phosphorylation. By using inhibitors, we found that JNK and p38 MAPK activation depends on Rac1 but not on phosphatidylinositol 3-kinase (PI3K), whereas AKT activation is independent of Rac1 but requires PI3K activity. Plitidepsin cytotoxicity diminishes by Rac1 inhibition or by the blockage of JNK and p38 MAPK using 4-(4-fluorophenyl)2-(4- methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580), but not by PI3K inhibition using wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). It is remarkable that plitidepsin and dacarbazine, the alkylating agent most active for treating metastatic melanoma, show a synergistic antiproliferative effect that was paralleled at the level of JNK activation. These results indicate that Rac1/JNK activation is critical for cell cycle arrest and apoptosis induction by plitidepsin in melanoma cells. They also support the combined use of plitidepsin and dacarbazine in in vivo studies.
引用
收藏
页码:1093 / 1101
页数:9
相关论文
共 40 条
[31]   Structure - Activity relationships of the didemnins [J].
Sakai, R ;
Rinehart, KL ;
Kishore, V ;
Kundu, B ;
Faircloth, G ;
Gloer, JB ;
Carney, JR ;
Namikoshi, M ;
Sun, F ;
Hughes, RG ;
Gravalos, DG ;
deQuesada, TG ;
Wilson, GR ;
Heid, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (14) :2819-2834
[32]   Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma [J].
Shields, Janiel M. ;
Thomas, Nancy E. ;
Cregger, Melissa ;
Berger, Aaron J. ;
Leslie, Michael ;
Torrice, Chad ;
Hao, Honglin ;
Penland, Shannon ;
Arbiser, Jack ;
Scott, Glynis ;
Zhou, Tong ;
Bar-Eli, Menashe ;
Bear, James E. ;
Der, Channing J. ;
Kaufmann, William K. ;
Rimm, David L. ;
Sharpless, Norman E. .
CANCER RESEARCH, 2007, 67 (04) :1502-1512
[33]   Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes [J].
Straight, AM ;
Oakley, K ;
Moores, R ;
Bauer, AJ ;
Patel, A ;
Tuttle, RM ;
Jimeno, J ;
Francis, GL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (01) :7-14
[34]   Plitidepsin cellular binding and Rac1/JNK pathway activation depend on membrane cholesterol content [J].
Suarez, Yajaira ;
Gonzalez-Santiago, Laura ;
Zarich, Natasha ;
Davalos, Alberto ;
Aranda, Juan F. ;
Alonso, Miguel A. ;
Lasuncion, Miguel A. ;
Rojas, Jose Maria ;
Munoz, Alberto .
MOLECULAR PHARMACOLOGY, 2006, 70 (05) :1654-1663
[35]   Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin [J].
Taddei, ML ;
Chiarugi, P ;
Cuevas, C ;
Ramponi, G ;
Raugei, G .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) :2082-2088
[36]   Akt is activated in response to an apoptotic signal [J].
Tang, D ;
Okada, H ;
Ruland, J ;
Liu, LQ ;
Stambolic, V ;
Mak, TW ;
Ingram, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30461-30466
[37]   Antiangiogenic activity of aplidine, a new agent of marine origin [J].
Taraboletti, G ;
Poli, M ;
Dossi, R ;
Manenti, L ;
Borsotti, P ;
Faircloth, GT ;
Broggini, M ;
D'Incalci, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (12) :2418-2424
[38]   JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells [J].
Teraishi, F ;
Wu, S ;
Sasaki, J ;
Zhang, L ;
Davis, JJ ;
Guo, W ;
Dong, F ;
Fang, B .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (19-20) :2382-2389
[39]   INK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species [J].
Ventura, JJ ;
Cogswell, P ;
Flavell, RA ;
Baldwin, AS ;
Davis, RJ .
GENES & DEVELOPMENT, 2004, 18 (23) :2905-2915
[40]   Regulation of apoptotic c-Jun N-terminal kinase signaling by a stabilization-based feed-forward loop [J].
Xu, ZH ;
Kukekov, NV ;
Greene, LA .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (22) :9949-9959